[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

World Cancer Diagnostics Market Key Players: Strategic Assessments of Major Suppliers and Emerging Market Entrants

December 2011 | 80 pages | ID: LF2FF4AB6C1EN
Venture Planning Group

US$ 2,000.00 US$ 2,500.00 -20 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report presents strategic analyses of major current and emerging suppliers of cancer diagnostic products in terms of their sales, market shares, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.

Contains 80 pages
  • Abbott
  • AdnaGen
  • Agensys
  • Altana
  • Ambrilia Biopharma
  • AMDL
  • BD
  • Beckman Coulter
  • Biofield
  • Biomedical Diagnostics
  • bioMerieux
  • Bio-Rad
  • Biotrol/B. Braun
  • CeMines
  • Cepheid
  • CIS/BIO
  • Cliniqa
  • Correlogic Systems
  • Cytyc
  • Daiichi
  • DakoCytomation
  • diaDexus
  • DiagnoCure
  • Diagnostic Systems
  • Dianon
  • DiaSorin
  • Digene
  • Eiken
  • Enterix
  • Enzo Biochem
  • Epigenomics
  • Exact Sciences
  • Fujirebio
  • Gen-Probe
  • Gene Logic
  • Green Cross
  • Grifols-Quest
  • Guided Therapeutics
  • Ibex Technologies
  • Immunicon
  • Ipsogen
  • Kyowa Medex
  • Matritech
  • Molecular Diagnostics
  • Myriad Genetics
  • Nippon Flour Mills
  • OncoLab
  • Ortho-Clinical Diagnostics
  • Panacea Pharmaceuticals
  • Polartechnics
  • Polymedco
  • PreMD
  • Quest Diagnostics Nichols Institute
  • Roche Diagnostics
  • Scantibodies
  • Siemens
  • Targeted Diagnostics
  • Tosoh
  • Trylon
  • Wako Chemicals
  • Worldwide Medical
  • Zila


More Publications